日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Camrelizumab Plus Nab-paclitaxel in Patients with Previously Treated Advanced Urothelial Carcinoma: A Multicenter Phase II Study

卡瑞利珠单抗联合白蛋白紫杉醇治疗既往接受过治疗的晚期尿路上皮癌患者：一项多中心 II 期研究

期刊:Cancer Communications
影响因子:24.9
doi:10.34133/cancomm.0025
Li, Haifeng; Chen, Meiting; Huang, Riqing; Rong, Qixiang; Hao, Jing; Zheng, Qiufan; Su, Yanhong; Shu, Ditian; Zhang, Yue; Yang, Wei; Lei, Xuefen; Cai, Yuchen; Xue, Cong; An, Xin; Shi, Yanxia
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone as First-Line Therapy for Patients With Unfavorable Cancer of Unknown Primary: A Multicenter, Retrospective Cohort Study

PD-1/PD-L1抑制剂联合化疗与单纯化疗作为一线治疗原发灶不明且预后不良的癌症患者的疗效比较：一项多中心回顾性队列研究

期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70124
Huang, Riqing; Li, Haifeng; Li, Shuo; Shu, Ditian; Chen, Rishang; Zheng, Zhousan; Gao, Tinghua; Chen, Meiting; Hu, Anqi; Huang, Yunjie; Zheng, Qiufan; An, Xin; Xue, Cong; Cai, Yuchen; Shi, Yanxia
PD-L1
肿瘤
PD-1
肿瘤免疫
发表日期：2025
文献求助 收藏

Bevacizumab, tislelizumab and nab-paclitaxel for previously untreated metastatic triple-negative breast cancer: a phase II trial

贝伐珠单抗、替雷利珠单抗和白蛋白紫杉醇联合治疗既往未接受治疗的转移性三阴性乳腺癌：一项 II 期试验

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-011314
Chen, Meiting; Huang, Riqing; Rong, Qixiang; Yang, Wei; Shen, Xiujiao; Sun, Qi; Shu, Ditian; Jiang, Kuikui; Xue, Cong; Peng, Jing; An, Xin; Li, Haifeng; Xu, Fei; Shi, Yanxia
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Impacts of genomic alterations on the efficacy of HER2-targeted antibody-drug conjugates in patients with metastatic breast cancer

基因组改变对转移性乳腺癌患者HER2靶向抗体药物偶联物疗效的影响

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-06082-5
Huang, Riqing; Hu, Anqi; Rong, Qixiang; Shu, Ditian; Chen, Meiting; Yang, Wei; Zhang, Yue; Zheng, Qiufan; An, Xin; Xue, Cong; Li, Haifeng; Shi, Yanxia
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Efficacy and safety of modified bleomycin administration with EP chemotherapy in adult male patients with germ cell tumors: a retrospective study

改良博来霉素联合EP方案化疗治疗成年男性生殖细胞肿瘤患者的疗效和安全性：一项回顾性研究

期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-025-03774-2
Shu, Ditian; Huang, Riqing; Chen, Meiting; Li, Haifeng; An, Xin; Xue, Cong; Hu, Anqi; Zhou, Fangjian; Yao, Kai; Liu, Zhuowei; Shi, Yanxia
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Prognostic index for predicting outcomes of trastuzumab deruxtecan in HER2 expressing metastatic breast cancer: a real-world multicenter study

预测曲妥珠单抗德鲁替康治疗HER2阳性转移性乳腺癌疗效的预后指数：一项真实世界多中心研究

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf174
Xue, Cong; Liao, Qianyi; Huang, Riqing; Huang, Yunjie; Chen, Rishang; Yang, Zhenhua; Shen, Xiujiao; Li, Haifeng; Rong, Qixiang; Shu, Ditian; Pan, Fei; Shi, Yanxia; Chen, Meiting
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Clinical outcome and genomic biomarkers of immune checkpoint inhibitor-based therapies for cancer of unknown primary: a multicenter, real-world study

免疫检查点抑制剂疗法治疗原发灶不明癌症的临床结果和基因组生物标志物：一项多中心真实世界研究

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-025-06261-3
Huang, Yunjie; Huang, Riqing; Chen, Meiting; Zheng, Zhousan; Li, Haifeng; Chen, Rishang; Gao, Tinghua; Shu, Ditian; Hu, Anqi; Zheng, Qiufan; An, Xin; Shi, Yanxia; Xue, Cong
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Sex-based Differences and Comparative Predictive Value of MELD 3.0 in Simultaneous Liver-Kidney Transplantation Waitlist Outcomes After Standardization of Listing Criteria in the United States

美国标准化登记标准后，基于性别的差异以及MELD 3.0在同时肝肾移植等待名单结果中的比较预测价值

期刊:Transplantation Direct
影响因子:1.9
doi:10.1097/TXD.0000000000001781
Leven, Emily A; Li, Ditian; Bagiella, Emilia; Schiano, Thomas D; Tal Grinspan, Lauren
发表日期：2025
文献求助 收藏

Effect of chemotherapy alone or combined with immunotherapy for locally advanced or metastatic genitourinary small cell carcinoma: a real-world retrospective study

化疗单独或联合免疫疗法治疗局部晚期或转移性泌尿生殖系统小细胞癌的疗效：一项真实世界回顾性研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-023-11473-2
Huang, Riqing; Chen, Meiting; Li, Haifeng; An, Xin; Xue, Cong; Hu, Anqi; Shu, Ditian; Yang, Wei; Zhou, Fangjian; Sui, Dan; Yao, Kai; Li, Yonghong; Wu, Zhiming; Li, Zhiyong; Liu, Zhuowei; Shi, Yanxia
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2023
文献求助 收藏

Paravalvular regurgitation after transcatheter aortic valve replacement in intermediate-risk patients: a pooled PARTNER 2 study

中危患者经导管主动脉瓣置换术后瓣周反流：PARTNER 2 研究汇总分析

期刊:EuroIntervention
影响因子:9.5
doi:10.4244/EIJ-D-20-01293
Chau, Katherine H; Chen, Shmuel; Crowley, Aaron; Redfors, Bjorn; Li, Ditian; Hahn, Rebecca T; Douglas, Pamela S; Alu, Maria C; Finn, Matthew T; Kodali, Susheel; Jaber, Wael A; Rodriguez, Leonardo; Thourani, Vinod H; Pibarot, Philippe; Leon, Martin B
发表日期：2022
文献求助 收藏